Company snapshot
Market Cap
$208B
Mega-cap2016 — today
10-Year Price
+154%
2016 — today
52-Week Range
$271.18$444.12
Current $381.50· 64%
Featured in rankings
S&P500NASDAQDow JonesMost Undervalued Healthcare StocksBest Healthcare Dividend StocksMost Undervalued Value StocksMost Undervalued Dividend StocksMost Undervalued Growth StocksCheapest Large-Cap Stocks
Rankings recomputed after each US market close — see where AMGN stands against peers.
Similar companies
| Company | P/E | Div yield |
|---|---|---|
| NVONovo Nordisk A/S | 10.7 | 4.1% |
| TMOThermo Fisher Scientific Inc. | 33.0 | 0.3% |
| GILDGilead Sciences, Inc. | -54.8 | 2.2% |
| ABTAbbott Laboratories | 33.1 | 2.4% |
| AZNAstraZeneca PLC | 24.6 | 2.0% |
| NVSNovartis AG | 21.0 | 3.4% |
| PFEPfizer Inc. | 36.6 | 6.2% |
| DHRDanaher Corporation | 36.1 | 0.7% |
Healthcare companies of comparable size — each one shown against its own 10-year range, not a sector average. Browse all stocks we cover.
Valuation in context
P/E ratio
23.7
Above average
Pricier than usual over the last 10 years
Sector median 25.2in line with sector
P/B ratio
17.8
Above average
Pricier than usual over the last 10 years
Sector median 2.5above sector
EV / EBITDA
15.2
Historically pricey
Historically pricey — last 10 years
Sector median 15.4in line with sector
Dividend Yield
2.6%
Below average
Below the 10-year average
Sector median 1.7%above sector
PEG ratio
2.3
Above average
Pricier than usual over the last 10 years
Sector median 1.4above sector
FCF Yield
4.9%
Historically low
Historically low relative to the last 10 years
Sector median -10.1%above sector